CDC cyclosporiasis investigation reportedly widened, with outbreak now linked to 15 states

The Centers for Disease Control and Prevention has reportedly expanded the scope of its investigation into a cyclosporiasis outbreak, linking the case cluster to 15 U.S. states, according to a report published by The Washington Post and cited by The Guardian. The new reporting said CDC added six states after investigators previously focused on a smaller set of jurisdictions.

The Guardian reported that the expansion follows Michigan’s announcement that it had recorded the first two U.S. deaths associated with cyclosporiasis. The update suggests CDC’s field epidemiology work and case identification in additional regions are now reaching the threshold used to describe broader geographic spread.

The reported change would mean the “largest known” cyclosporiasis outbreak in the United States now involves 15 states, The Guardian said, citing unnamed individuals familiar with the matter. Those individuals reportedly told The Washington Post that CDC’s scope widened to include additional states after more cases were identified.

Among the states named in The Guardian’s report are Arkansas and Iowa, though the article did not list every additional state in the expanded count. The update described the new states as part of a six-state addition to the overall figure being tracked by investigators.

Cyclosporiasis is an intestinal illness caused by the Cyclospora parasite. Outbreak tracking typically relies on laboratory confirmation, interviews that connect people to shared food or other exposures, and follow-up case counts by state and local health departments, with agencies updating the geographic descriptions as investigators confirm new patients.

The reported CDC expansion underscores how outbreak descriptions can shift over time as public health laboratories and clinicians identify additional confirmed cases. It also highlights the administrative role of state health agencies, which report data to CDC and coordinate local investigations, including outreach and monitoring for additional illnesses.

While the CDC action described in the reporting has not been presented here through a directly cited agency statement or dataset, the update as described would indicate a widened federal-state investigation footprint. Public guidance and reporting expectations often follow such geographic updates, as clinicians and labs in newly included states may become more aware of when to test for Cyclospora and how to report results.